Citations

Clear

3314 citation(s) found for "Do, Alexander".

QIM22-194: Using the Merlin Assay to Reduce Sentinel Lymph Node Biopsy Rates and Its Complications: A Retrospective Cohort Study
Sadurní, Mariana B. , Quattrocchi, Enrica , Kobic, Ajdin, Sominidi‐Damodaran, Sindhuja , Meerstein, Lisette, Dwarkasing, Jvalini, Bridges, Alina G. , Meves, Alexander , Hieken, Tina J.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 31, 2022 | Volume: 20 | Issue: 3.5 | Pages: QIM22-194

10.6004/jnccn.2021.7223 Get It

HSR22-126: Key Factors Associated With Breast Cancer Clinical Trial Enrollment in Underrepresented Minority Groups
Baksh, Mizba , Hochwald, Alexander , David, Hodge, Advani, Pooja , Spaulding, Aaron , Ailawadhi, Sikander

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 31, 2022 | Volume: 20 | Issue: 3.5 | Pages: HSR22-126

10.6004/jnccn.2021.7195 Get It

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Klonoff, David C. , Wang, Jing , Rodbard, David , Kohn, Michael A. , Li, Chengdong , Liepmann, Dorian , Kerr, David , Ahn, David , Peters, Anne L. , Umpierrez, Guillermo E. , Xu, Nicole Y. , Nguyen, Kevin T. , Simonson, Gregg D. , Agus, Michael S. D. , Armaiz-Peña, Gustavo , Basu, Ananda , Battelino, Tadej , Yeshiwas, Sewagegn , Bequette, B. Wayne , Blevins, Thomas , Breton, Marc D. , Castle, Jessica R. , Close, Kelly L. , Drincic, Angela, Dungan, Kathleen , Ejskjær, Niels , Espinoza, Juan , Fleming, G. Alexander , Forlenza, Gregory P. , Freckmann, Guido , Galindo, Rodolfo J. , Gómez, Ana María , Gutow, Hanna A. , Hovorka, Roman , Ji, Linong , Joubert, Michaël , Koliwad, Suneil K. , Lal, Rayhan , Lansang, M. Cecilia , Lee, Wei-An , Leelarathna, Lalantha , Lind, Marcus , Mahoney, Katherine , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras , Mayorov, Alexander Yur'evich , Messler, Jordan , Mohan, Viswanathan , Nichols, James H. , O’Neal, David N. , Pasquel, Francisco J. , Philis‐Tsimikas, Athena , Phillip, Moshe , Rayman, Gerry , Russell, Steven J. , Spanakis, Elias K. , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E. , Wolpert, Howard , Zilbermint, Mihail , Kovatchev, Boris , Seley, Jane Jeffrie , Xu, Nicole Y , Nguyen, Kevin T , Simonson, Gregg , Agus, Michael S D , Al-Sofiani, Mohammed E , Armaiz-Pena, Gustavo , Bailey, Timothy S , Basu, Ananda , Battelino, Tadej , Bekele, Sewagegn Yeshiwas , Benhamou, Pierre-Yves , Bequette, B Wayne , Blevins, Thomas , Breton, Marc D , Castle, Jessica R , Chase, James Geoffrey , Chen, Kong , Choudhary, Pratik , Clements, Mark A , Close, Kelly L , Cook, Curtiss B , Doyle, Francis J , Drincic, Angela , Dungan, Kathleen M , Edelman, Steven V , Ejskjaer, Niels , Espinoza, Juan , Fleming, G Alexander , Forlenza, Gregory P , Freckmann, Guido , Galindo, Rodolfo J , Gomez, Ana Maria , Gutow, Hanna A , Heinemann, Lutz , Hirsch, Irl B , Hoang, Thanh D , Hovorka, Roman , Jendle, Johan H , Ji, Linong , Joshi, Shashank R , Joubert, Michael , Koliwad, Suneil K , Lal, Rayhan A , Lansang, M Cecilia , Lee, Wei-An Andy , Leelarathna, Lalantha , Leiter, Lawrence A , Lind, Marcus , Litchman, Michelle L , Mader, Julia K , Mahoney, Katherine M , Mankovsky, Boris , Masharani, Umesh , Mathioudakis, Nestoras N , Mayorov, Alexander , Messler, Jordan , Miller, Joshua D , Mohan, Viswanathan , Nichols, James H , Nørgaard, Kirsten , O'Neal, David N , Pasquel, Francisco J , Philis-Tsimikas, Athena , Pieber, Thomas , Phillip, Moshe , Polonsky, William H , Pop-Busui, Rodica , Rayman, Gerry , Rhee, Eun-Jung , Russell, Steven J , Shah, Viral N , Sherr, Jennifer L , Sode, Koji , Spanakis, Elias K , Wake, Deborah J , Waki, Kayo , Wallia, Amisha , Weinberg, Melissa E , Wolpert, Howard , Wright, Eugene E , Zilbermint, Mihail , Kovatchev, Boris , Kohn, Michael , Umpierrez, Guillermo E. , Peters, Anne L , Ahn, David T , Liepmann, Dorian , Bailey, Timothy S. , Chen, Kong Y. , Choudhary, Pratik , Cook, Curtiss B. , Danne, Thomas , Doyle, Francis J. , Heinemann, Lutz , Hirsch, Irl B. , Leiter, Lawrence A. , Mader, Julia K. , Pop‐Busui, Rodica , Shah, Viral N. , Sode, Koji , Wright, Eugene E.

Mayo Clinic

Journal of Diabetes Science and Technology | March 29, 2022 | Volume: 17 | Issue: 5 | Pages: 1226-1242

10.1177/19322968221085273 | PMID 35348391 Get It

Background: A composite metric for the quality of glycemia from continuous glucose monitor (CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data. Methods: We assembled a data set of 14-day CGM tracings from 225 insulin-treated adults with diabetes. Using a balanced incomplete block design, 330 clinicians who were highly experienced with CGM analysis and interpretation ranked the CGM tracings from best to worst quality of glycemia. We used principal component analysis and multiple regressions to develop a model to predict the clinician ranking based on seven standard metrics in an Ambulatory Glucose Profile: very low–glucose and low-glucose hypoglycemia; very high–glucose and high-glucose hyperglycemia; time in range; mean glucose; and coefficient of variation. Results: The analysis showed that clinician rankings depend on two components, one related to hypoglycemia that gives more weight to very low-glucose than to low-glucose and the other related to hyperglycemia that likewise gives greater weight to very high-glucose than to high-glucose. These two components should be calculated and displayed separately, but they can also be combined into a single Glycemia Risk Index (GRI) that corresponds closely to the clinician rankings of the overall quality of glycemia (r = 0.95). The GRI can be displayed graphically on a GRI Grid with the hypoglycemia component on the horizontal axis and the hyperglycemia component on the vertical axis. Diagonal lines divide the graph into five zones (quintiles) corresponding to the best (0th to 20th percentile) to worst (81st to 100th percentile) overall quality of glycemia. The GRI Grid enables users to track sequential changes within an individual over time and compare groups of individuals. Conclusion: The GRI is a single-number summary of the quality of glycemia. Its hypoglycemia and hyperglycemia components provide actionable scores and a graphical display (the GRI Grid) that can be used by clinicians and researchers to determine the glycemic effects of prescribed and investigational treatments.
Understanding Suboptimal Response to Immune Checkpoint Inhibitors
Zhu, Mojun , Pedersen, Katrina S. , Foster, Nathan R. , Jaszewski, Brandy L., Liu, Xin , Hirdler, Jacob B. , An, Zesheng , Bekaii‐Saab, Tanios , Yan, Yiyi , Hubbard, Joleen H., Yoon, Harry H. , Revzin, Alexander , Fernández-Zapico, Martín E. , Overman, Michael J. , Dong, Haidong , Bekaii-Saab, Tanios S , Pedersen, Katrina , Zhang, Henan , Hálfdánarson, Þorvarður R. , Boland, Patrick M. , Hubbard, Joleen M. , Wee, Wen , McWilliams, Robert R. , Dong, Haidong

Mayo Clinic

Advanced Biology | March 27, 2022 | Volume: 7 | Issue: 4 | Pages: No page available

10.1002/adbi.202101319 | PMID 35343107 Get It

AbstractImmune checkpoint inhibitors (ICIs), as a novel class of anticancer therapy, can be more efficacious and less toxic than chemotherapy, but their clinical success is confined to certain tumor types. Elucidating their targets, mechanisms and scope of action, and potential synergism with chemotherapy and/or targeted therapies are critical to widen their clinical indications. Treatment response to an ICI targeting programmed death‐1 (anti‐PD‐1) is sought to be understood here by conducting a preplanned correlative analysis of a phase II clinical trial in patients with small bowel adenocarcinoma (SBA). The cytolytic capacity of circulating immune cells in cancer patients using a novel ex vivo cytotoxicity assay is evaluated, and the utility of circulating biomarkers is investigated to predict and monitor the treatment effect of anti‐PD‐1. Baseline expression of Bim and NKG7 and upregulation of CX3CR1 in circulating T cells are associated with the clinical benefit of anti‐PD‐1 in patients with SBA. Overall, these findings suggest that the frequency and cytolytic capacity of circulating, effector immune cells may differentiate clinical response to ICIs, providing a strong rationale to support immune monitoring using patient peripheral blood.
Mapping multiregional image-localized biopsies to MRI habitats reveal biologically significant glioma tissue states and patterns of cellular subpopulations
Curtin, Lee , Bond, Kamila M. , Jackson, Pamela , Hawkins‐Daarud, Andrea , Velez, Sebastian, Shakir, Neha, Urcuyo, Javier , León, Gustavo De , Singleton, Kyle , Langworthy, Jazlynn , Clark-Swanson, Kamala R., Lassiter-Morris, Yvette, Paulson, Lisa, Sereduk, Christopher, Krishna, Chandan , Zimmerman, Richard S. , Patra, Devi Prasad, Smith, Kris A. , Donev, Kliment , Tran, Nhan L. , Hu, Leland , Plaisier, Christopher, Mrugała, Maciej M. , Canoll, Peter , Swanson, Kristin R. , Swanson, Kristin R , Tran, Nhan L , Velez, Sebastian, Shakir, Neha, Leon, Gustavo De, Clark-Swanson, Kamala R., Lassiter-Morris, Yvette, Paulson, Lisa, Sereduk, Chris , Bendok, Bernard R. , Nakaji, Peter , Baxter, Leslie C. , Plaisier, Christopher, Anderson, Alexander R A , Grinband, Jack , Al‐Dalahmah, Osama , Rubin, Joshua B

Mayo Clinic

No container title available | March 26, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2022.03.23.485500 Get It

Abstract Background Magnetic Resonance Imaging (MRI) is the mainstay for neurosurgical oncology but not for informing us about glioma biology. An obstacle to developing MR-based glioma biomarkers is the absence of rigorous correlation between MRI features and glioma biology as assessed in multi-regional biopsies, within and across patients. Methods We directly addressed this obstacle by collating a unique cohort of 202 MRI-localized biopsies from 58 patients. We define a low-dimensional transcriptional pseudotime continuum along which heterogeneous high-grade glioma (HGG) samples organize both within and across patients. Results We observe three polarized transcriptional tissue states: infiltrated brain, immune/inflammatory, and proliferative associated with patterns of cohabitation of cellular subpopulations. The states and deconvolved populations show correlation with enhancement status on T1Gd MRI. Moreover, discrete MRI habitats, regions sharing common imaging features, defined as combinations of high or low signal intensity across multiparametric MRI revealed 14 MRI habitats. We order the MRI habitats according to the average pseudotime on the transcriptional continuum. We find that MRI habitats with low pseudotime (associated with early tumor development and diffusely invaded brain tissue) localized at the periphery of the tumor whilst high pseudotime either proliferative or immune/inflammatory states were towards the core of the lesion. We find that composition of MRI habitats are impacted by MGMT status and patient sex. Conclusion This suggests that ongoing aggregation of MRI-localized biopsies may augment our projection of biology onto MRI habitats to support tracking of the evolution of cellular ecologies within and across each patient’s tumor over time. Key Points Trajectory inference of HGG samples reveals a continuum connecting three polarized tissue states reflecting transitions in cellular population ecologies and gene set enrichment Combining multiparametric MRI features into regional MRI habitats reveal clinically-distinct patterns of cell co-habitation and tissue state MGMT methylation status shifts the cellular patterns of cohabitation within MRI habitats Importance of the Study Regional heterogeneity is a defining characteristic of high-grade glioma (HGG). Mapping the transcriptomic biology of multiregionally sampled MRI-localized biopsies from high-grade gliomas onto a low-dimensional space reveals a continuum between three primary tissue states: infiltrated brain, immune/inflammatory, and proliferative. Each state is associated with distinct cell cohabitation ecologies. Transitions between the tissue states coordinate with changes in tumor composition, revealing potential direct connections between tumor biology shifts and their manifestation on clinical imaging.
Provisional Reduction and External Fixation of Acute Displaced Intra-articular Calcaneus Fractures: Surgical Technique and Clinical Results
Yan, Alan Y. , Shafiq, Babar , Canton, Stephen P. , Olson, Joshua T., Cole, Peter Alexander

Mayo Clinic

Techniques in Foot & Ankle Surgery | March 23, 2022 | Volume: 22 | Issue: 1 | Pages: 35-43

10.1097/btf.0000000000000353 Get It

The treatment of calcaneus fractures has been a topic of ongoing debate with controversies regarding the best treatment options and algorithms. Sparse literature exists examining the role of external fixation in initial reduction and the maintenance of bony alignment. The authors describe a technique of a medially based 3-pin provisional external fixation for the treatment of a displaced intra-articular calcaneus fractures with the review of 26 patients with an average follow-up of 26 months. A fourth pin utilized in the case of tongue-type fractures is introduced as an important adjunct to this treatment paradigm. Level of Evidence: Diagnostic Level IV—therapeutic. See Instructions for Authors for a complete description of levels of evidence.
Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1
Sethi, Sanjeev , Madden, Benjamin, Moura, Marta Casal , Nasr, Samih H., Klomjit, Nattawat, Gross, LouAnn, Negron, Vivian, Charlesworth, M. Cristine, Alexander, Mariam P. , Leung, Nelson , Haas, Mark, Klomjit, Nattawat , Casal Moura, Marta , Specks, Ulrich , Leung, Nelson , Alexander, Mariam P , Klomjit, Nattawat , Sethi, Sanjeev , Madden, Benjamin, Nasr, Samih H., Gross, LouAnn, Negron, Vivian, Charlesworth, M. Cristine, Fervenza, Fernando C , Haas, Mark

Mayo Clinic

Journal of the American Society of Nephrology | March 23, 2022 | Volume: 33 | Issue: 5 | Pages: 1033-1044

10.1681/asn.2021111488 | PMID 35321939 Get It

Background Membranous nephropathy (MN) is a common cause of proteinuria in patients receiving a hematopoietic stem cell transplant (HSCT). The target antigen in HSCT-associated MN is unknown. Methods We performed laser microdissection and tandem mass spectrometry (MS/MS) of glomeruli from 250 patients with PLA2R-negative MN to detect novel antigens in MN. This was followed by immunohistochemical (IHC)/immunofluorescence (IF) microscopy studies to localize the novel antigen. Western blot analyses using serum and IgG eluted from frozen biopsy specimen to detect binding of IgG to new 'antigen'. Results MS/MS detected a novel protein, protocadherin FAT1 (FAT1), in nine patients with PLA2R-negative MN. In all nine patients, MN developed after allogeneic HSCT (Mayo Clinic discovery cohort). Next, we performed MS/MS in five patients known to have allogeneic HSCT-associated MN (Cedar Sinai validation cohort). FAT1 was detected in all five patients by MS/MS. The total spectral counts for FAT1 ranged from 8 to 39 (mean±SD, 20.9±10.1). All 14 patients were negative for known antigens of MN, including PLA2R, THSD7A, NELL1, PCDH7, NCAM1, SEMA3B, and HTRA1. Kidney biopsy specimens showed IgG (2 to 3+) with mild C3 (0 to 1+) along the GBM; IgG4 was the dominant IgG subclass. IHC after protease digestion and confocal IF confirmed granular FAT1 deposits along the GBM. Lastly, Western blot analyses detected anti-FAT1 IgG and IgG4 in the eluate obtained from pooled frozen kidney biopsy tissue and in the serum of those with FAT1-asssociated MN, but not from those with PLA2R-associated MN. Conclusions FAT1-associated MN appears to be a unique type of MN associated with HSCT. FAT1-associated MN represents a majority of MN associated with HSCT.
Thymic Mucoepidermoid Carcinoma
Murase, Takayuki, Nakano, Satsuki, Sakane, Tadashi, Domen, Hiromitsu, Chiyo, Masako, Nagasaka, Satoshi, Tanaka, Michio, Kawahara, Yutaka, Toishi, Masayuki, Tanaka, Takuji, Nakamura, Shota, Sawabata, Noriyoshi, Okami, Jiro, Mukaida, Hidenori, Tzankov, Alexandar, Szolkowska, Malgorzata, Porubsky, Stefan, Marx, Alexander, Roden, Anja C., Inagaki, Hiroshi, Tzankov, Alexandar , Porubský, Štefan , Tzankov, Alexandar , Murase, Takayuki, Nakano, Satsuki, Sakane, Tadashi , Domen, Hiromitsu , Chiyo, Masako, Nagasaka, Satoshi, Tanaka, Michio, Kawahara, Yutaka, Toishi, Masayuki, Tanaka, Takuji, Nakamura, Shota, Sawabata, Noriyoshi, Okami, Jiro, Mukaida, Hidenori, Szolkowska, Malgorzata, Marx, Alexander, Roden, Anja C., Inagaki, Hiroshi

Mayo Clinic

American Journal of Surgical Pathology | March 23, 2022 | Volume: 46 | Issue: 8 | Pages: 1160-1169

10.1097/pas.0000000000001886 | PMID 35319525 Get It

Thymic mucoepidermoid carcinoma (MEC) is a rare tumor, and its characteristics remain to be clarified. Here we investigated 20 cases of thymic MEC to systematically characterize its clinical, histopathologic, and molecular features. The median age of the patients was 56 years (range, 19 to 80 y), there was a slight male predilection (3:2), and 44% of the patients were asymptomatic at diagnosis. The median tumor size was 6.8 cm in diameter, 55% were pT1 tumors, and 50% were TNM stage I tumors. When 4 tumor grading systems for salivary MEC (Armed Forces Institutes of Pathology, Brandwein, modified Healey, and the Memorial Sloan-Kettering) were employed, low-grade, intermediate-grade, and high-grade tumors accounted for 35% to 70%, 5% to 25%, and 25% to 50%, respectively. Many histologic variants were noted, and 70% of the cases were classified as nonclassic variants. MAML2 rearrangement was detected in 56% of cases, and the fusion partner was CRTC1 in all cases. CRTC1-MAML2 fusion was associated with lower pT classification and lower TNM stage. The overall survival rate of all patients was 69% and 43% at 5 and 10 years, respectively. Worse overall survival was associated with higher pT stage, higher TNM stage, residual tumors, greater tumor size, high-grade tumor histology (Armed Forces Institutes of Pathology and Memorial Sloan-Kettering, but not the other 2), and with the absence of CRTC1-MAML2 fusion. Of note, none of the patients with CRTC1-MAML2 fusion-positive tumors died during the follow-up. In conclusion, the clinicopathologic and molecular findings of thymic MEC presented here are expected to contribute to the management of this rare tumor.
Role of adipose tissue grafting and adipose-derived stem cells in peripheral nerve surgery
Saffari, Tiam M., Saffari, TiamM, Vyas, Krishna S., Shin, Alexander Y. , Vyas, Krishna S. , Saffari, Sara , Shin, Alexander Y , Saffari, Tiam M., Vyas, Krishna S., Mardini, Samir

Mayo Clinic

Neural Regeneration Research | March 22, 2022 | Volume: 17 | Issue: 10 | Pages: 2179-2184

10.4103/1673-5374.336870 | PMID 35259826 Get It

The application of autologous fat grafting in reconstructive surgery is commonly used to improve functional form. This review aims to provide an overview of the scientific evidence on the biology of adipose tissue, the role of adipose-derived stem cells, and the indications of adipose tissue grafting in peripheral nerve surgery. Adipose tissue is easily accessible through the lower abdomen and inner thighs. Non-vascularized adipose tissue grafting does not support oxidative and ischemic stress, resulting in variable survival of adipocytes within the first 24 hours. Enrichment of adipose tissue with a stromal vascular fraction is purported to increase the number of adipose-derived stem cells and is postulated to augment the long-term stability of adipose tissue grafts. Basic science nerve research suggests an increase in nerve regeneration and nerve revascularization, and a decrease in nerve fibrosis after the addition of adipose-derived stem cells or adipose tissue. In clinical studies, the use of autologous lipofilling is mostly applied to secondary carpal tunnel release revisions with promising results. Since the use of adipose-derived stem cells in peripheral nerve reconstruction is relatively new, more studies are needed to explore safety and long-term effects on peripheral nerve regeneration. The Food and Drug Administration stipulates that adipose-derived stem cell transplantation should be minimally manipulated, enzyme-free, and used in the same surgical procedure, e.g. adipose tissue grafts that contain native adipose-derived stem cells or stromal vascular fraction. Future research may be shifted towards the use of tissue-engineered adipose tissue to create a supportive microenvironment for autologous graft survival. Shelf-ready alternatives could be enhanced with adipose-derived stem cells or growth factors and eliminate the need for adipose tissue harvest.
Surgery for aortic recoarctation in children less than 10 years old: A single‐center experience in Siberia, Russia
Egunov, O.A. , Кривощеков, Е. В. , Cetta, Frank , Aa, Sokolov , Sviazov, Evgenii A. , Shipulin, V. V. , Egunov, Oleg A , Krivoshchekov, Evgeny V , Sokolov, Alexander A , Shipulin, Vladimir V

Mayo Clinic

Journal of Cardiac Surgery | March 22, 2022 | Volume: 37 | Issue: 6 | Pages: 1627-1632

10.1111/jocs.16435 | PMID 35315136 Get It